Drug Landscape ›
Medical Air ›
Regulatory · United States
Marketing authorisations
FDA — authorised 16 June 2013
Application: NDA205711
Marketing authorisation holder: AIR LIQUIDE AMERICA SPECIALITY GASES
Local brand name: MEDICAL AIR, USP
Indication: GAS — INHALATION
Status: approved
Read official source →
FDA — authorised 5 July 2013
Application: NDA205765
Marketing authorisation holder: LINDE NORTH AMERICA INC
Status: approved
FDA — authorised 14 July 2013
Application: NDA205820
Marketing authorisation holder: NORCO INC
Status: approved
FDA — authorised 2 August 2013
Application: NDA205890
Marketing authorisation holder: MATHESON TRI-GAS INC
Local brand name: MEDICAL AIR, USP
Indication: GAS — INHALATION
Status: approved
Read official source →
FDA — authorised 5 August 2013
Application: NDA205909
Marketing authorisation holder: PRAXAIR DISTRIBUTION INC
Local brand name: MEDICAL AIR, USP
Indication: GAS — INHALATION
Status: approved
Read official source →
FDA — authorised 5 August 2013
Application: NDA205910
Marketing authorisation holder: PRAXAIR DISTRIBUTION MID-ATLANTIC LLC
Local brand name: MEDICAL AIR, USP
Indication: GAS — INHALATION
Status: approved
Read official source →
FDA — authorised 31 August 2013
Application: NDA205992
Marketing authorisation holder: UNITED STATES WELDING INC
Local brand name: MEDICAL AIR, USP
Indication: GAS — INHALATION
Status: approved
Read official source →
FDA — authorised 1 September 2013
Application: NDA205999
Marketing authorisation holder: ACETYLENE OXYGENE CO
Local brand name: MEDICAL AIR, USP
Indication: GAS — INHALATION
Status: approved
Read official source →
FDA — authorised 7 September 2013
Application: NDA206023
Marketing authorisation holder: AIRGAS USA LLC
Status: approved
FDA — authorised 22 April 2014
Application: NDA207036
Marketing authorisation holder: CEE KAY SUPPLY
Local brand name: MEDICAL AIR, USP
Indication: GAS — INHALATION
Status: approved
Read official source →
FDA — authorised 12 May 2014
Application: NDA207114
Marketing authorisation holder: AMERICAN WELDING AND GAS INC
Local brand name: MEDICAL AIR, USP
Indication: GAS — INHALATION
Status: approved
Read official source →
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 13
Most-reported reactions
Decompression Sickness — 2 reports (15.38%) Product Quality Issue — 2 reports (15.38%) Underdose — 2 reports (15.38%) Anaphylactic Reaction — 1 report (7.69%) Atelectasis — 1 report (7.69%) Blood Gases Abnormal — 1 report (7.69%) Brain Natriuretic Peptide Increased — 1 report (7.69%) Cardiac Arrest — 1 report (7.69%) Cardiomegaly — 1 report (7.69%) Condition Aggravated — 1 report (7.69%)
Source database →
Medical Air in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Medical Air approved in United States?
Yes. FDA authorised it on 16 June 2013; FDA authorised it on 5 July 2013; FDA authorised it on 14 July 2013.
Who is the marketing authorisation holder for Medical Air in United States?
AIR LIQUIDE AMERICA SPECIALITY GASES holds the US marketing authorisation.